Rigel Pharmaceuticals
RIGL
$1.10
Share price
0.00%
Change (1 day)
-2.65%
Change (1 year)
Categories
Rigel Pharmaceuticals (RIGL) Fails to deliver data
Key failure to deliver metrics for Rigel Pharmaceuticals:
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.01 M
- Last 3 months FTD volume: $0.02 M
- Last year FTD volume: $0.89 M
Failures to deliver for Rigel Pharmaceuticals (RIGL) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Rigel Pharmaceuticals (RIGL) - since 2013
Volume in USD (price x number of shares), data since 2013Rigel Pharmaceuticals (RIGL) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.02 M | -98.12% |
| 2023 | $1.11 M | -68.64% |
| 2022 | $3.56 M | -47.14% |
| 2021 | $6.75 M | 159.94% |
| 2020 | $2.59 M | 284.04% |
| 2019 | $0.67 M | -85.02% |
| 2018 | $4.51 M | 17.28% |
| 2017 | $3.85 M | 24.72% |
| 2016 | $3.08 M | 166.47% |
| 2015 | $1.15 M | -47.8% |
| 2014 | $2.21 M | 151.65% |
| 2013 | $0.88 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 AstraZeneca AZN | $0.10 B | $0.17 B | 🇬🇧 UK |
 Sangamo Therapeutics
SGMO | $0.14 M | $1.62 M | 🇺🇸 USA |
 ChemoCentryx CCXI | N/A | $8.56 M | 🇺🇸 USA |